The first bloodless heart transplant in Asia was successfully completed by medical professionals at Ahmedabad’s Marengo CIMS Hospital.
The patient, 52-year-old Chandraprakash Garg, underwent this ground-breaking operation while experiencing end-stage heart failure and ischemic dilated cardiomyopathy.
The donor, a 33-year-old man who tragically passed away in a car accident, was a very special person.
Bloodless heart transplant procedures are extremely complex and demand a high level of competence. They entail precise blood loss evaluation and management, ultimately doing away with the necessity for blood transfusions.
Given the possible hazards and difficulties associated with blood transfusions, this represents a substantial development.
Blood transfusion can potentially result in risks and consequences during complex surgery. Since blood is actually an organ, transfusions are treated as complete organ transplants that must be carefully monitored and managed.
Notably, the patient was released from the hospital after only nine days, as opposed to the average 21 to 24 days for individuals receiving a traditional heart transplant.
This zero-transfusion strategy decreases transfusion-related short- and long-term problems, shortens hospital stays, and improves overall clinical outcomes.
A blood transfusion-free heart transplant, according to Dr. Dhiren Shah, who oversaw the procedure, is an exceptional milestone in cardiac surgery and exemplifies the considerable advancements made in surgical methods and technology.
He also spoke about using the bloodless heart transplant method to construct a Hemostasis Center of Excellence.
Dr. Niren Bhavsar, a cardiothoracic anesthetist who participated in the procedure, meantime, emphasized the significance of constant monitoring of the patient’s vital signs and other data, controlling blood pressure, and managing coagulation factors.
